Xcelience Strengthens Development Services With Addition to Executive Team
An industry veteran, Skultety has over 26 years experience in pharmaceutical research and formulation development. He has held senior executive positions such as Vice President of Scientific Development at Aptuit Inc., Vice President of Pharmaceutics at Quintiles, and Director of Solids Formulations Development at Hoechst Marion Roussel (formerly Marion Merrill Dow and Marion Labs). He began his career in 1982 as a research pharmacist for Abbott Laboratories.
"Paul brings a wealth of experience and leadership to Xcelience. He is focused and realizes what it takes to work in the demanding customer services arena that we face everyday and he still enjoys it," stated Derek G. Hennecke, President and CEO.
Skultety's unique background in pharmaceutical formulation compliments Xcelience's diverse offerings to sponsors. It expands the company 's team structure and ability to become a direct extension of sponsors' laboratories.
"Paul's knowledge truly strengthens Xcelience's arsenal of services for our clients," said Randall H. Guthrie, Vice President. "We look forward to his insights and leadership."
In addition, Skultety currently has nine registered patents with the United States Patent and Trademark Office related to formulation and pharmaceutical composition. He has spearheaded over 17 published articles and presentations and is a member of the American Association of Pharmaceutical Sciences (AAPS) and the Controlled Release Society.
About Xcelience
Xcelience is the premier source for unsurpassed quality in drug development services. The company brings together the industry's most experienced and talented scientists, consistently and efficiently moving compounds through the research and development continuum to regulatory approval.
Since 1997, the Tampa-based laboratory has been developing formulations for clients throughout the pharmaceutical industry. Xcelience's unique corporate structure creates project teams that work intensively with each client, bringing an extension of their own organization into the Xcelience lab. The lab uses only state-of-the-art equipment, highlighted by the patented Xcelodose which fills API directly to capsules (Xcelodose is a registered trademark of Capsugel BVBA). This and other technologies give Xcelience unparalleled speed to market without compromising its absolute commitment to quality.
Xcelience Strengthens Development Services With Addition to Executive Team
2908 readers online...
- Syndication Directory
- General
- College of American Path
- Too Many Rock Concerts L
- FitzSimmons Joins Americ
- Latest Generation of Pro
- Celebrities Use New NonI
- Wiemer Joins QHR as Vice
- New Online Venture Offer
- America Hears Donates He
- Autism Hangout Helps Com
- Medical Solutions Announ
- Trusted LASIK Surgeons i
- CareerSaving Back Surger
- New Finasteride Treatmen
- Addiction Web Generation
- New York Plastic Surgeon
- SKIL Vision Group Change
- Adverse Drug Events Conf
- Combined Insurance Repor
- Urgent Care Company Offe
- Synergy Broadcast System
- Third Coast Reflexology
- Developer of Mobile Hosp
- New Technologies Allow T
- An American Appeal to Ov
- The Revolution in Breast
- Experimental Drug Stops
- With Students Convenienc
- Tamaris Announces Foot a
- MyStudentBody Announces
- Wired For Success Consid
- PDI Donates Infection Pr
- WinScribe Designates Inn
- RareShare Launches Early
- Newborn in the WinScribe
- U.S. Sleep Aids Market G
- Brits Afraid of Hearing
- TriMix gel Achieves Succ
- Recovering Quadriplegic
- Angel MedFlight Air Ambu
- VisionSciences Inc. Laun
- Childrens Rights Group c
- Inflexxion Inc. Launches
- iCRco Adds Elan Vita of
- Three Popular Sweeteners
- Shoulder Injuries Report
- ConceiveAbilities Announ
- Baptist Medical Center S
- Angus Munros New Memoir
- Log Your Moles and Save
- TheraBootie LLC Introduc